Drug intelligence / Profile preview

Fuke Duanhongyin Capsules

Development stage: Unknown
Lead developer: Zhuzhou Qianjin Pharmaceutical
Administration: Oral

Overview

Fuke Duanhongyin Capsules (妇科断红饮胶囊) is a traditional Chinese medicine (TCM) developed and manufactured by Zhuzhou Qianjin Pharmaceutical. It is formulated from a mixture of herbal extracts, including Radix Paeoniae Rubra, Herba Leonuri, Radix et Rhizoma Notoginseng, Herba Agrimoniae, Carbonized Radix Sanguisorbae, and Carbonized Pollen Typhae. The capsule is indicated for cooling blood, resolving stasis, and stopping bleeding, and is primarily used to treat dysfunctional uterine bleeding (DUB) and abnormal uterine bleeding (AUB) associated with the TCM syndrome of blood heat.

Brand names: Fuke Duanhongyin Capsules妇科断红饮胶囊
Other names: Fuke Duanhongyin Capsule

Targets

HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on Fuke Duanhongyin Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuke Duanhongyin Capsules.

Explore the full profile